Stock Events

Stock Events

Vivos 

$0.065000
12
-$0.00-2.99% Today

Statistics

Day High
0.065
Day Low
0.065
52W High
0.1547
52W Low
0.0425
Volume
38,500
Avg. Volume
1,372,753
Mkt Cap
29.55M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

19OctExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0.01
-0
-0
Expected EPS
N/A
Actual EPS
-0.0008

Financials

-10,392.86%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
56,000Revenue
-5.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RDGL. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical offers robotic-assisted surgical systems, competing in the broader field of advanced medical technologies, including cancer treatment.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific Corporation provides various medical devices used in interventional medical specialties, competing in the oncology space with solutions that may overlap with Vivos' offerings.
Medtronic
MDT
Mkt Cap102.97B
Medtronic plc offers medical technologies, services, and solutions, including those for treating cancer, making it a competitor in the medical device and therapy market.
Stryker
SYK
Mkt Cap119.69B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments, competing with Vivos' therapeutic solutions.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but its involvement in surgical solutions places it in indirect competition with companies like Vivos in the broader medical device market.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie Inc. engages in the discovery, development, manufacture, and sale of a broad line of pharmaceuticals, including cancer treatments, competing in the pharmaceutical and biotechnology industry against Vivos' therapies.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson operates in the healthcare field, offering products and services, including cancer treatment solutions, which places it in competition with Vivos in the healthcare and medical device sector.
Pfizer
PFE
Mkt Cap149.38B
Pfizer Inc. is a research-based biopharmaceutical company that develops and manufactures healthcare products including cancer drugs, competing in the pharmaceuticals sector with Vivos.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. is a global healthcare company that offers cancer treatment solutions, including pharmaceuticals and vaccines, competing in the healthcare and pharmaceutical industry with Vivos.

About

Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Show more...
CEO
Dr. Michael K. Korenko Ph.D.
Employees
1
Country
United States
ISIN
US92858K2042

Listings

OTC Link
US
RDGL

0 Comments

Share your thoughts

FAQ

What is Vivos stock price today?▼
The current price of RDGL is $0.06 USD — it has decreased by -2.99% in the past 24 hours. Watch Vivos stock price performance more closely on the chart.
What is Vivos stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Vivos stocks are traded under the ticker RDGL.
Is Vivos stock price growing?▼
RDGL stock has risen by +2.36% compared to the previous week, the month change is a +4% rise, over the last year Vivos has showed a -43.53% decrease.
What is Vivos market cap?▼
Today Vivos has the market capitalization of 29.55M
What were Vivos earnings last quarter?▼
RDGL earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Vivos revenue for the last year?▼
Vivos revenue for the last year amounts to 56,000 USD.
What is Vivos net income for the last year?▼
RDGL net income for the last year is -5.82M USD.
How many employees does Vivos have?▼
As of June 18, 2026, the company has 1 employees.
In which sector is Vivos located?▼
Vivos operates in the Health & Wellness sector.
When did Vivos complete a stock split?▼
The last stock split for Vivos was on June 28, 2019 with a ratio of 1:8.
Where is Vivos headquartered?▼
Vivos is headquartered in Kennewick, United States.